2022. ADVANCEMENTS IN TARGETED CANCER THERAPIES: FROM MONOCLONAL ANTIBODIES TO IMMUNOTHERAPY. International Journal of Food and Nutritional Sciences. 11, 12 (Jan. 2022), 17887–17896.